Bone metabolism in adolescents with anorexia nervosa

Journal of Endocrinological Investigation

Volumn 34, Issue 4, 2011, Pages 324-332

  Misra, M ^a   Klibanski, A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adolescents; Anorexia nervosa; Bone density; Bone microarchitecture; Bone turnover; Cortisol; Estrogen; GH; Ghrelin; Leptin; Peptide YY; Testosterone

Indexed keywords

ADIPONECTIN; ALENDRONIC ACID; ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTRADIOL; ESTROGEN; GHRELIN; GLUCOCORTICOID; GROWTH HORMONE; HUMAN GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN; PEPTIDE YY; PLACEBO; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; RECOMBINANT SOMATOMEDIN C; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; VITAMIN D;

AMENORRHEA; ANDROGEN BLOOD LEVEL; ANOREXIA NERVOSA; APPETITE; BODY COMPOSITION; BODY WEIGHT; BONE DEFECT; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; CALCIUM ABSORPTION; CORTICAL BONE; DISEASE ASSOCIATION; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ESTROGEN BLOOD LEVEL; FEMUR NECK; FRACTURE; GROWTH HORMONE BLOOD LEVEL; HIP; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMIC AMENORRHEA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MENSTRUAL CYCLE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPENIA; PATHOPHYSIOLOGY; PHALANX; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; SPINE; TESTOSTERONE BLOOD LEVEL; TRABECULAR BONE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANOREXIA NERVOSA; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CLINICAL TRIALS AS TOPIC; GONADAL HORMONES; HUMANS; HYPOTHALAMIC HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN-LIKE GROWTH FACTOR I; PITUITARY-ADRENAL SYSTEM;

EID: 79957964216     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7505     Document Type: Review

References (69)

1. Lucas AR, Beard CM, O'Fallon WM, Kurland LT. 50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry 1991, 148: 917-22.
2. Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999, 84: 4702-12.
3. Misra M, Aggarwal A, Miller KK, et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004, 114: 1574-83.
4. Misra M, Katzman DK, Cord J, et al. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008, 93: 3029-36.
5. Soyka LA, Misra M, Frenchman A, Miller KK, Grinspoon S, Schoenfeld DA, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002, 87: 4177-85.
6. Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008, 93: 1231-7.
7. Biller B, Saxe V, Herzog D, Rosenthal D, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989, 68: 548-54.
8. Castro J, Toro J, Lazaro L, Pons F, Halperin I. Bone mineral density in male adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2002, 41: 613-8.
9. Milos G, Spindler A, Rüegsegger P, et al. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos lnt 2005, 16: 783-90.
10. Lawson EA, Miller KK, Bredella MA, et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2010, 46: 458-63.
11. Bredella MA, Misra M, Miller KK, et al. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology 2008, 249: 938-46.
12. Walsh CJ, Phan CM, Misra M, et al. Finite Element and Trabecular Structure Analysis in Anorexia Nervosa via Flat-Panel Volume CT. Radiology 2010, 257: 167-74.
13. DiVasta AD, Ringelheim J, Bristol SK, Feldman HA, Gordon CM. Skeletal measurements by quantitative ultrasound in adolescents and young women with anorexia nervosa. J Pediatr 2007, 150: 286-90, 90 e1.
14. Oswiecimska J, Ziora K, Pluskiewicz W, et al. Skeletal status and laboratory investigations in adolescent girls with anorexia nervosa. Bone 2007, 41: 103-10.
15. Mora S, Pitukcheewanont P, Kaufman F, Nelson J, Gilsanz V. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 1999, 14: 1664-71.
16. Misra M, Miller KK, Cord J, et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007, 92: 2046-52.
17. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996, 81: 3864-70.
18. Riggs B. The mechanisms of estrogen regulation of bone resorption. J Clin Invest 2000, 106: 1203-4.
19. rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23: 279-302.
20. Boyar RM, Katz J, Finkelstein JW, et al. Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med 1974, 291: 861-5.
21. Miller KK, Lawson EA, Mathur V, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007, 92: 1334-9.
22. Misra M, Miller KK, Tsai P, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006, 91: 1027-33.
23. Gordon CM, Goodman E, Emans SJ, et al. Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr 2002, 141: 64-70.
24. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998, 19: 55-79.
25. Misra M, Miller K, Bjomson J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003, 88: 5615-23.
26. Fazeli P, Lawson E, Prabhakaran R, et al. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2010, 95: 4889-97.
27. Misra M, McGrane J, Miller KK, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 2009, 45: 493-8.
28. Abad V, Chrousos G, Reynolds J, et al. Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat. J Bone Miner Res 2001, 16: 1879-85.
29. Cino M, Greenberg G. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 2002, 97: 915-21.
30. Di Somma C, Pivonello R, Loche S, et al. Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol (Oxf) 2002, 56: 153-8.
31. Hermus A, Smals A, Swinkels L, et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995, 80: 2859-65.
32. Lettgen B, Jeken C, Reiners C. Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 1994, 8: 667-70.
33. Misra M, Miller KK, Almazan C, et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2004, 89: 4972-80.
34. Lawson EA, Misra M, Meenaghan E, et al. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab 2009, 94: 1367-71.
35. Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hartzeil D, Baile CA. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 2005, 20: 994-1001.
36. Hamrick MW, Pennington C, Newton D, Xie D, Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004, 34: 376-83.
37. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100: 197-207.
38. Misra M, Miller KK, Kuo K, et al. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005, 289: E373-81.
39. Misra M, Prabhakaran R, Miller KK, et al. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 2006, 59: 598-603.
40. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004, 351: 987-97.
41. Maccarinelli G, Sibilia V, Torsello A, et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 2005, 184: 249-56.
42. Kim SW, Her SJ, Park SJ, et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005, 37: 359-69.
43. Misra M, Miller K, Kuo K, et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005, 289: E347-56.
44. Misra M, Miller KK, Stewart V, et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005, 90: 5082-7.
45. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf) 2004, 60: 592-9.
46. Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006, 91: 1491-5.
47. Baldock PA, Sainsbury A, Couzens M, et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002, 109: 915-21.
48. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418: 650-4.
49. Utz AL, Lawson EA, Misra M, et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008, 43: 135-9.
50. Housova J, Anderlova K, Krizová J, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005, 90: 1366-70.
51. Pannacciulli N, Bunt JC, Ortega E, et al. Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J Clin Endocrinol Metab 2006, 91: 1600-3.
52. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2004, 89: 1833-7.
53. Luo XH, Guo LJ, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006, 21: 1648-56.
54. Luo XH, Guo LJ, Yuan LQ, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005, 309: 99-109.
55. Jürimäe J, Rembel K, Jürimäe T, Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 2005, 37: 297-302.
56. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003, 33: 646-51.
57. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005, 289: E735-45.
58. Wojcik MH, Meenaghan E, Lawson EA, Misra M, Klibanski A, Miller KK. Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone, 46: 796-800.
59. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int 2008, 19: 289-94.
60. Audi L, Vargas DM, Gussinye M, Yeste D, Marti G, Carrascosa A. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res 2002, 51: 497-504.
61. Misra M, Tsai P, Anderson EJ, et al. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr 2006, 84: 698-706.
62. Loud KJ, Gordon CM, Micheli LJ, Field AE. Correlates of Stress Fractures Among Preadolescent and Adolescent Girls. Pediatrics 2005, 115: e399-406.
63. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999, 84: 4489-96.
64. Klibanski A, Biller B, Schoenfeld D, Herzog D, Saxe V. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995, 80: 898-904.
65. Golden NH, Lanzkowsky L, Schebendach J, Palestra CJ, Jacobson MS, Shenker IR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002, 15: 135-43.
66. Strokosch GR, Friedman AJ, Wu SC, Kamin M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 2006, 39: 819-27.
67. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002, 87: 4935-41.
68. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002, 87: 2883-91.
69. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005, 90: 3179-85.